Mr Mrs Miss Ms Dr Other

Dr
Susan
Riley

Senior European Patent Attorney

York Office

Electronics

Telephone. +44(0) 1904 732 120
Email. [email protected]

Experience

With a background in both physics and electronic engineering, Susan is comfortable working with a wide variety of subject matter. Her academic background is in solid state physics with a particular interest in semiconductor and magnetic devices.

Susan has a keen interest in artificial intelligence and has drafted and prosecuted multiple AI-related applications in a variety of fields, including telecommunications, bioinformatics and oncology. She particularly enjoys working with cross-disciplinary inventions which use AI for medical purposes. Her work in biotechnology has been praised by academics and clinicians alike for its high quality.

Susan also has extensive experience in drafting and prosecuting patent applications in the fields of quantum technology, telecommunications, software, and mobile technology.

Qualifications

Patent Attorney

Europe


MSCI

Physics with Theoretical Physics, Imperial College London

PHD

Electronic & Electrical Engineering, University of Leeds

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.